Assertio Therapeutics's total assets for Q4 2024 were $284.73M, an increase of 3.16% from the previous quarter. ASRT total liabilities were $163.65M for the fiscal quarter, a 12.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.